Univariate Cox regression analysis | All-cause mortality | SUDEP | ||
HR (95% CI) | P value | HR (95% CI) | P value | |
Male | 1.25 (0.89 to 1.77) | 0.20 | 1.06 (0.57 to 1.97) | 0.86 |
Age (years) | 1.05 (1.03 to 1.06) | <0.001 | 1.01 (0.99 to 1.04) | 0.21 |
Repeat surgery | 1.22 (0.72 to 2.10) | 0.46 | 0.88 (0.37 to 2.11) | 0.78 |
Non-LEATs* | 1.04 (0.70 to 1.56) | 0.85 | 1.84 (0.77 to 4.38) | 0.17 |
Seizure outcome at last follow-up | ||||
Seizure free (ref) | 1 | 1 | 1 | 1 |
TCS | 1.77 (1.07 to 2.92) | 0.025 | 4.61 (2.03 to 10.44) | <0.001 |
Seizures other than TCS | 2.25 (1.49 to 3.41) | <0.001 | 2.83 (1.23 to 6.54) | 0.015 |
Living alone at last follow-up† | 1.60 (1.09 to 2.36) | 0.016 | 1.45 (0.70 to 2.98) | 0.32 |
Non-temporal lobe resection | 1.32 (0.90 to 1.94) | 0.16 | 1.65 (0.79 to 3.47) | 0.19 |
Multivariable Cox regression analysis | All-cause mortality | |||
HR (95% CI) | P value | |||
Age (years) | 1.05 (1.03 to 1.06) | <0.001 | ||
Seizure outcome at last follow-up | ||||
Seizure free (ref) | 1 | 1 | ||
TCS | 1.78 (1.07 to 2.96) | 0.027 | ||
Seizures other than TCS | 2.14 (1.41 to 3.23) | <0.001 | ||
Living alone at last follow-up† | 1.47 (1.01 to 2.13) | 0.045 |
Bold values denote statistical significance at the p < 0.05 level.
LEATs=ganglioglioma, dysembryoplastic neuroepithelial tumour, pleomorphic xanthoastrocytoma grade II, oligodendroglioma grade II, pilocytic astrocytoma, diffuse astrocytoma grade II and neurocytoma.
*Reference LEATs, meningioma and cavernous hemangioma.
†Children<18 years excluded.
LEATs, long-term epilepsy-associated tumours; SUDEP, sudden unexpected death in epilepsy; TCS, tonic–clonic seizures.